I was wondering about that too.

JLA, looks like we had the same idea!

Received this email today. I guess we cannot construe this as negative or positive, but may be of interest.

This is in response to your email dated August 17, 2020, to the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).

Thank you for sharing your suggestion. Please be assured that NIH scientists are considering all potential therapies and are exploring the most promising treatment approaches for COVID-19. NIH and Operation Warp Speed (OWS) are aware of leronlimab and its potential for COVID-19 and are awaiting any promising results from the ongoing company-sponsored trial. OWS aims to deliver 300 million doses of a safe, effective vaccine for COVID-19 by January 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics (collectively known as countermeasures).

Thank you for contacting NIAID.

Sincerely,


Kara M. Harris, MPH
Section Chief for Controlled Correspondence and Public Inquiries
Legislative Affairs and Correspondence Management Branch
Office of Communications and Government Relations
National Institute of Allergy and Infectious Diseases
National Institutes of Health

Scott Atlas contact info
swatlas@stanford.edu
University - Academic staff
Department: Research
Position: Hoover Senior Fellow
Hoover Institution, HHMB 350
434 Galvez Mall
Stanford University
Stanford, California 94305-6010

On Hannity tonight, the President said "The are therapeutics are great. We could have something very soon. And that's where you go in give a transfusion or a shot in hospitals and people are going to come out and they are going to walk out pretty soon after that and they are going to be in great shape. We are having tremendous success with that and you will be hearing about that soon."

I don't know of any "shot" other than leronlimab.

Wishful thinking?

CDYWinning, My mom had to wait 4 days for the funds to clear. TDA showed her money right away as available for trade, but apparently not if you want to trade OTC.

With the excitement of the potential covid indication, I have to keep reminding myself that we bought in for the HIV indication. Even if the covid thing never works out, seems like leronlimab might still be effective treatment for HIV (and possibly many other indications).

Thank you for the info. Disappointing.

I just listened to Fauci. He said monoclonal antibodies developed from people who have had the disease are the silver bullet. I listened twice. He wasn't talking about convalescent plasma. What am I missing? Leronlimab is not made from people who have had the disease. What is he talking about?

Anyone have any updates on this? Been in since 3/19 and wondering whatever happened with FDA approval. I assume delayed d/t COVID.

I sent him 2 emails, but I am sure he gets thousands per day. Probably never actually made it to him personally.

I don't think the company knows whether the SAEs are in the placebo group or in the treatment group. I think he was just saying a lot of very sick people in the sample and some deaths.

Does your friend know who the guest from Forbes, who mentioned
Cytodyn, was?

Been in since 2013. Very happy to finally see this thing take off. Pulled my initial investment at 6.2 yesterday and letting the rest ride. Hoping my hubby can retire early.

Actually, in my former life, I was a nurse and when I learned about ARDS it was Adult Respiratory Distress Syndrome as you can also see in this
articlehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392788/

Wow. And I thought I was doing well at $0.29. Long since 2013.

Got this from a friend. Not sure if anyone has any connections or if many of us contacted this reporter, maybe we could get some attention:

If leronlimab is still showing promise and not getting appropriate attention, maybe Sheryl Atkisson would investigate. She's getting some traction with the intersection of money, politics, and medicine.

I just saw that Sarah Wright died. Terribly sad. Makes me sick she couldn't get leronlimab.

Sorry if already posted
https://www.norwoodnews.org/bronx-hospitals-lead-nationwide-investigative-drug-trial-for-severe-lung-inflammation-from-covid-19/

I just did a search for other monoclonal antibodies being tested. Came across another one called lenzimulab in phase 3 trial. It is IV, so not as easy to administer. Some hopeful investors on ihub: https://investorshub.advfn.com/Humanigen-Inc-HGEN-26171/
Anyone have any insights into this or other direct competition?

Dr. Mike Hansen on YouTube shows excerpts of Dr. Patterson's paper at around 3:45. He doesn't mention treatments.

https://www.dailymail.co.uk/health/article-8286331/75-coronavirus-patients-experimental-HIV-cancer-drug-month.html

https://app.gotowebinar.com/index.html#737010235/3535563608599124494/1906312776119204622

On Yahoo board, it looks like people are listening to it, I am still getting that it will start shortly

My email confirmation and link to CC still says 9:30am Pacific.

Rapid Review response 2 days

FAQ

I think my paper could have profound implications for patient care and could save lives. Do you have an option for accelerating manuscript review? How do I request it?

For papers meeting basic criteria described here, authors may submit abstracts using the NEJM Rapid Review request form. Due to demand, NEJM is only able to accommodate a small percentage of Rapid Review requests. Standard response time for Rapid Reviews is within two (2) days.

International Business Times has their article up on their Facebook page. Some likes and shares of it might be in order. https://www.facebook.com/permalink.php?id=128026713884051&story_fbid=3154197987933560

Found this article written in German https://www.wallstreet-online.de/nachricht/12446570-anlegerverlag-cytodyn-richtig-los
translated and first line reads: CytoDyn is perhaps the greatest hope in the fight against the pandemic at the moment. Not sure, but maybe getting buzz in other countries.

Found this article written in German https://www.wallstreet-online.de/nachricht/12446570-anlegerverlag-cytodyn-richtig-los
translated and first line reads: CytoDyn is perhaps the greatest hope in the fight against the pandemic at the moment. Not sure, but maybe getting buzz in other countries.

Found this article written in German https://www.wallstreet-online.de/nachricht/12446570-anlegerverlag-cytodyn-richtig-los
translated and first line reads: CytoDyn is perhaps the greatest hope in the fight against the pandemic at the moment.

Thank you Black-Ops. From a naive CYDY investor since 2013, you really opened my eyes.